Dr. Dhillon has a PhD in Genetics from the University of Washington and worked as a researcher at the Fred Hutch Cancer Center for 8 years where she studied chemotherapy resistance in inherited breast and ovarian cancers. She then joined the Rivkin Center as Director of Scientific Programs, where she oversaw an international ovarian cancer research grants program, scientific symposia, and content for a breast and ovarian cancer education program. Currently, she is the Executive Director at the Cancer Vaccine Institute at the University of Washington, the largest academic institution devoted to the development of cancer vaccines. As ED she directs the overall strategic program goals and general administration of the CVI to accelerate the development of therapeutic and preventative cancer vaccines for some of the most common and deadly cancers.